Skip to main content
Equibles

CHAI · Core AI Holdings, Inc. · Documents

Track CHAI — free

Use CHAI with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research CHAI.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$0.18 0.00 (-2.54%)
Rebalance outlook locked
Market Cap
$4.78M
Shares
25.87M
Volume · Nov 12 2.46M Avg daily vol (3M) 5.41M

The company's filings, earnings calls and investor events, most recent first. Search and read these filings from Claude or ChatGPT with the SEC filings MCP server →

Annual report FY2025 Revenue $55.24M up 58.6% 20-F filed May 15, 2026
2026
Oct 30
Current report 6-K
Haggai Ravid appointed director after Marc Seelenfreund resignation

Core AI Holdings, Inc. appointed Haggai Ravid as an independent director on October 28, 2026, effective immediately, after Marc Seelenfreund resigned from the Board and its committees on October 27, 2026.

2 source passages
On October 27, 2026, Mr. Marc Seelenfreund notified Core AI Holdings, Inc., a British Columbia, Canada corporation (the “Company”), of his resignation as a member of the Company’s Board of Directors (the “Board”) and from all committees of the Board on which he served, effective immediately. On October 28, 2026, the Board appointed Mr. Haggai Ravid as a director of the Company, effective immediately, to fill the vacancy created by Mr. Seelenfreund’s resignation. Open the document at this passage
Sep 23
Current report 6-K
Current report

Core AI Holdings, Inc. received Nasdaq notice that shareholders’ equity of $2,429,389 fell below the $2,500,000 minimum for continued listing. It must submit a compliance plan by November 2, 2026; if accepted, Nasdaq may extend the cure period to March 17, 2027.

May 15
Annual report 20-F FY2025, ended Dec 31
Annual report for FY2025 AI summary on its way
Revenue $55.24M ▲ 58.6% Net loss $31.59M
2025
Apr 21
Annual report 20-F FY2024, ended Dec 31
Annual report for FY2024
Revenue $11.63M ▲ 41.3% Net loss $25.27M Diluted EPS -$154.66
Showing 1–50 of 314 documents
Key facts CIK 1649009 CUSIP 83013Q871 13F (30d) 9 filings 9 filers Visit website Investor relations